Welcome to Novo Nordisk in the United States


About Matthias von Herrath

Matthias von Herrath, MD, is vice president of Novo Nordisk’s type 1 diabetes team at the company’s Seattle research center. Matthias leads a diabetes translational unit, which is based on less conventional and innovative design for immune-based interventions.

Entries by Matthias von Herrath


What it’s like to GOBOLDLY every day

Matthias von Herrath, MD, Vice President of Novo Nordisk’s Diabetes R&D Center in Seattle, is one of the researchers featured in the GOBOLDLY campaign from the biopharmaceutical industry group, PhRMA.

Read the story

 


Explore more content

See all featured content


Subscribe to Perspectives

A place to find different points of view from inside Novo Nordisk and the communities we serve.